The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridine
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 40 (10), 1566-1571
- https://doi.org/10.1016/j.ejca.2004.02.019
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Preparation of Anti-human Thymidine Phosphorylase Monoclonal Antibodies Useful for Detecting the Enzyme Levels in Tumor Tissues.Biological & Pharmaceutical Bulletin, 1996
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Angiogenic activity of enzymesNature, 1994
- Angiogenic factorNature, 1992
- He's Not Going to Talk About In Vitro Predictive Assays Again, Is He?JNCI Journal of the National Cancer Institute, 1990
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosidesJournal of Medicinal Chemistry, 1979
- Primary Bioassay of Human Tumor Stem CellsScience, 1977